These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9824938)

  • 1. [Primary graft failure as the result of unsuspected severe steatosis in the donor liver].
    García Ureña MA; Moreno González E; Colina Ruíz-Delgado F; Jiménez Romero C; García García I; González-Pinto I; Loinaz Segurola C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):722-5. PubMed ID: 9824938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of primary non-function following adult-to-adult living donor liver transplantation.
    Hwang S; Lee SG; Lee YJ; Park KM; Choi DN; Ahn CS; Min PC
    Hepatogastroenterology; 2002; 49(47):1412-4. PubMed ID: 12239953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
    de Graaf EL; Kench J; Dilworth P; Shackel NA; Strasser SI; Joseph D; Pleass H; Crawford M; McCaughan GW; Verran DJ
    J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation.
    Yoo HY; Molmenti E; Thuluvath PJ
    Liver Transpl; 2003 Jan; 9(1):72-8. PubMed ID: 12514776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to the rational use of steatotic donor livers in liver transplantation.
    Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
    Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-factor analysis of initial poor graft function after orthotopic liver transplantation.
    Chen H; Peng CH; Shen BY; Deng XX; Shen C; Xie JJ; Dong W; Li HW
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):141-6. PubMed ID: 17374571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?
    Hałoń A; Patrzałek D; Rabczyński J
    Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.
    Deschênes M; Forbes C; Tchervenkov J; Barkun J; Metrakos P; Tector J; Alpert E
    Liver Transpl Surg; 1999 Sep; 5(5):357-61. PubMed ID: 10477834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 1999; ():23-34. PubMed ID: 11038623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor liver steatosis and graft selection for liver transplantation: a short review.
    Angelico M
    Eur Rev Med Pharmacol Sci; 2005; 9(5):295-7. PubMed ID: 16231593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal grafts: finding the correct treatment for fatty livers.
    Salizzoni M; Franchello A; Zamboni F; Ricchiuti A; Cocchis D; Fop F; Brunati A; Cerutti E
    Transpl Int; 2003 Jul; 16(7):486-93. PubMed ID: 12669196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steatosis in donor and transplant liver biopsies.
    Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
    Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
    Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.